-
Je něco špatně v tomto záznamu ?
Metastatic Adenoid Cystic Carcinoma at the Base of the Tongue and Duplicate Breast Cancer Diagnosed During Restaging
K. Licková, V. Mandys, R. Soumarová, M. Michna, M. Šteffl
Jazyk angličtina Země Řecko
Typ dokumentu časopisecké články, kazuistiky
NLK
Free Medical Journals
od 2004 do Před 2 roky
PubMed Central
od 2017
Europe PubMed Central
od 2017
Open Access Digital Library
od 2004-01-01
PubMed
39477377
DOI
10.21873/invivo.13798
Knihovny.cz E-zdroje
- MeSH
- adenoidně cystický karcinom * terapie diagnóza patologie sekundární MeSH
- kombinovaná terapie MeSH
- lidé středního věku MeSH
- lidé MeSH
- nádory jazyka * patologie terapie diagnóza MeSH
- nádory prsu * patologie terapie diagnóza MeSH
- staging nádorů * MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- kazuistiky MeSH
BACKGROUND/AIM: Adenoid cystic carcinoma (AdCC) is a rare malignant tumor that primarily affects the salivary glands but can also occur in other organs. Low incidence and unpredictable clinical behavior make AdCC one of the most difficult head and neck tumors to treat. CASE REPORT: We present the case of a 54-year-old woman with AdCC localized at the base of the tongue, following radical surgical and oncological therapy. Due to advances in palliative oncological treatment, there is a more than five-year survival period before the progression of metastatic disease. Considering the rare occurrence of this disease, a literature search was also conducted, and therapy options are discussed. Ensuring a sufficient extent of the surgical procedure is still a challenge, and most specialists agree that subsequent postoperative radiotherapy reduces the risk of local recurrence. The effective dose of radiotherapy to the area of the primary tumor and lymph nodes is not clearly defined. CONCLUSION: The distinct biological behavior of AdCC results in varying sensitivity to chemotherapy or radiotherapy compared to treatments commonly used for head and neck squamous cell carcinomas. Treatment recommendations for these rarer tumors are based mainly on case reports and small clinical trials. The acquired therapeutic experience can contribute to prolonging the survival period of patients and improving their prognosis and quality of life.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25003580
- 003
- CZ-PrNML
- 005
- 20250206104427.0
- 007
- ta
- 008
- 250121s2024 gr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.21873/invivo.13798 $2 doi
- 035 __
- $a (PubMed)39477377
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gr
- 100 1_
- $a Licková, Kateřina $u Department of Oncology, Charles University, Faculty of Medicine and University Hospital Královské Vinohrady, Prague, Czech Republic; katerina.lickova@fnkv.cz
- 245 10
- $a Metastatic Adenoid Cystic Carcinoma at the Base of the Tongue and Duplicate Breast Cancer Diagnosed During Restaging / $c K. Licková, V. Mandys, R. Soumarová, M. Michna, M. Šteffl
- 520 9_
- $a BACKGROUND/AIM: Adenoid cystic carcinoma (AdCC) is a rare malignant tumor that primarily affects the salivary glands but can also occur in other organs. Low incidence and unpredictable clinical behavior make AdCC one of the most difficult head and neck tumors to treat. CASE REPORT: We present the case of a 54-year-old woman with AdCC localized at the base of the tongue, following radical surgical and oncological therapy. Due to advances in palliative oncological treatment, there is a more than five-year survival period before the progression of metastatic disease. Considering the rare occurrence of this disease, a literature search was also conducted, and therapy options are discussed. Ensuring a sufficient extent of the surgical procedure is still a challenge, and most specialists agree that subsequent postoperative radiotherapy reduces the risk of local recurrence. The effective dose of radiotherapy to the area of the primary tumor and lymph nodes is not clearly defined. CONCLUSION: The distinct biological behavior of AdCC results in varying sensitivity to chemotherapy or radiotherapy compared to treatments commonly used for head and neck squamous cell carcinomas. Treatment recommendations for these rarer tumors are based mainly on case reports and small clinical trials. The acquired therapeutic experience can contribute to prolonging the survival period of patients and improving their prognosis and quality of life.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a adenoidně cystický karcinom $x terapie $x diagnóza $x patologie $x sekundární $7 D003528
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a nádory jazyka $x patologie $x terapie $x diagnóza $7 D014062
- 650 12
- $a nádory prsu $x patologie $x terapie $x diagnóza $7 D001943
- 650 12
- $a staging nádorů $7 D009367
- 650 _2
- $a kombinovaná terapie $7 D003131
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a kazuistiky $7 D002363
- 700 1_
- $a Mandys, Václav $u Department of Pathology, Charles University, Faculty of Medicine and University Hospital Královské Vinohrady, Prague, Czech Republic
- 700 1_
- $a Soumarová, Renata $u Department of Oncology, Charles University, Faculty of Medicine and University Hospital Královské Vinohrady, Prague, Czech Republic
- 700 1_
- $a Michna, Martin $u Department of Radiology and Nuclear Medicine, Charles University, Faculty of Medicine and University Hospital Královské Vinohrady, Prague, Czech Republic
- 700 1_
- $a Šteffl, Martin $u Department of Otorhinolaryngology, Charles University, Faculty of Medicine and University Hospital Královské Vinohrady, Prague, Czech Republic
- 773 0_
- $w MED00175831 $t In Vivo $x 1791-7549 $g Roč. 38, č. 6 (2024), s. 3125-3130
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39477377 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250121 $b ABA008
- 991 __
- $a 20250206104423 $b ABA008
- 999 __
- $a ok $b bmc $g 2263372 $s 1239587
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 38 $c 6 $d 3125-3130 $e - $i 1791-7549 $m In Vivo $n In Vivo $x MED00175831
- LZP __
- $a Pubmed-20250121